Moreover, the expression of TYR, MITF, EDNRB, and TRP-1/2 was elevated again when rosiglitazone and GW acted together on melanoma cells, as PPAR-γ was activated (Fig. 4c and d; Fig. S3a-d). The gene discussed is TYRP1; the disease is melanoma.